Xu, X.; Zhang, H.; Meng, K.; Cai, H.; Liu, W.; Song, L.; Zhang, Z.; Zhu, Q.; Han, X.; Han, Y.;
et al. Limosilactobacillus reuteri ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged Mice. Antioxidants 2025, 14, 58.
https://doi.org/10.3390/antiox14010058
AMA Style
Xu X, Zhang H, Meng K, Cai H, Liu W, Song L, Zhang Z, Zhu Q, Han X, Han Y,
et al. Limosilactobacillus reuteri ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged Mice. Antioxidants. 2025; 14(1):58.
https://doi.org/10.3390/antiox14010058
Chicago/Turabian Style
Xu, Xin, Hongwei Zhang, Kun Meng, Hongying Cai, Weiwei Liu, Liye Song, Zihan Zhang, Qijun Zhu, Xiling Han, Yunsheng Han,
and et al. 2025. "Limosilactobacillus reuteri ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged Mice" Antioxidants 14, no. 1: 58.
https://doi.org/10.3390/antiox14010058
APA Style
Xu, X., Zhang, H., Meng, K., Cai, H., Liu, W., Song, L., Zhang, Z., Zhu, Q., Han, X., Han, Y., & Yang, P.
(2025). Limosilactobacillus reuteri ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged Mice. Antioxidants, 14(1), 58.
https://doi.org/10.3390/antiox14010058
